Cargando…

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy

BACKGROUND: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellular spaces. The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met. Symptoms and ejection fraction decrease may occur in cardiac amyloidosis only in case of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Alexandre Marins, Ferreira, Suzane Garcia, Nacif, Marcelo Souto, Ribeiro, Mario Luiz, de Freitas, Marcos Raimundo Gomes, Mesquita, Cláudio Tinoco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245844/
https://www.ncbi.nlm.nih.gov/pubmed/27992035
http://dx.doi.org/10.5935/abc.20160191
_version_ 1782496892022685696
author Rocha, Alexandre Marins
Ferreira, Suzane Garcia
Nacif, Marcelo Souto
Ribeiro, Mario Luiz
de Freitas, Marcos Raimundo Gomes
Mesquita, Cláudio Tinoco
author_facet Rocha, Alexandre Marins
Ferreira, Suzane Garcia
Nacif, Marcelo Souto
Ribeiro, Mario Luiz
de Freitas, Marcos Raimundo Gomes
Mesquita, Cláudio Tinoco
author_sort Rocha, Alexandre Marins
collection PubMed
description BACKGROUND: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellular spaces. The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met. Symptoms and ejection fraction decrease may occur in cardiac amyloidosis only in case of poor prognosis. Myocardial strain detected by two-dimensional speckle tracking echocardiography can indicate changes in myocardial function at early stages of the disease. OBJECTIVE: To determine the accuracy of left ventricular longitudinal strain by two-dimensional speckle tracking echocardiography in patients with familial amyloidosis caused by Val30Met transthyretin mutation. METHODS: Eighteen consecutive patients, carriers of transthyretin mutation, were evaluated by two-dimensional speckle tracking echocardiography, by which myocardial strain curves were obtained, following the American Society of Echocardiography recommendations. RESULTS: Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease. As the three groups were compared by the Mann-Whitney test, we found a statistically significant difference between groups 1 and 2 in the mean longitudinal tension (p=0.01), mean basal longitudinal strain (p=0.014); in mean longitudinal tension and mean longitudinal strain between groups 1 and 3 (p=0.005); and in the ratio of longitudinal strain of apical septum segment to longitudinal strain of basal septum (p=0.041) between groups 2 and 3. CONCLUSION: Left ventricular longitudinal strain detected by two-dimensional speckle tracking echocardiography is able to diagnose left ventricular dysfunction in early stages of familial amyloidosis caused by transthyretin Val30Met mutation.
format Online
Article
Text
id pubmed-5245844
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Cardiologia - SBC
record_format MEDLINE/PubMed
spelling pubmed-52458442017-01-25 Speckle Tracking and Transthyretin Amyloid Cardiomyopathy Rocha, Alexandre Marins Ferreira, Suzane Garcia Nacif, Marcelo Souto Ribeiro, Mario Luiz de Freitas, Marcos Raimundo Gomes Mesquita, Cláudio Tinoco Arq Bras Cardiol Original Articles BACKGROUND: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellular spaces. The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met. Symptoms and ejection fraction decrease may occur in cardiac amyloidosis only in case of poor prognosis. Myocardial strain detected by two-dimensional speckle tracking echocardiography can indicate changes in myocardial function at early stages of the disease. OBJECTIVE: To determine the accuracy of left ventricular longitudinal strain by two-dimensional speckle tracking echocardiography in patients with familial amyloidosis caused by Val30Met transthyretin mutation. METHODS: Eighteen consecutive patients, carriers of transthyretin mutation, were evaluated by two-dimensional speckle tracking echocardiography, by which myocardial strain curves were obtained, following the American Society of Echocardiography recommendations. RESULTS: Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease. As the three groups were compared by the Mann-Whitney test, we found a statistically significant difference between groups 1 and 2 in the mean longitudinal tension (p=0.01), mean basal longitudinal strain (p=0.014); in mean longitudinal tension and mean longitudinal strain between groups 1 and 3 (p=0.005); and in the ratio of longitudinal strain of apical septum segment to longitudinal strain of basal septum (p=0.041) between groups 2 and 3. CONCLUSION: Left ventricular longitudinal strain detected by two-dimensional speckle tracking echocardiography is able to diagnose left ventricular dysfunction in early stages of familial amyloidosis caused by transthyretin Val30Met mutation. Sociedade Brasileira de Cardiologia - SBC 2017-01 /pmc/articles/PMC5245844/ /pubmed/27992035 http://dx.doi.org/10.5935/abc.20160191 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Rocha, Alexandre Marins
Ferreira, Suzane Garcia
Nacif, Marcelo Souto
Ribeiro, Mario Luiz
de Freitas, Marcos Raimundo Gomes
Mesquita, Cláudio Tinoco
Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title_full Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title_fullStr Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title_full_unstemmed Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title_short Speckle Tracking and Transthyretin Amyloid Cardiomyopathy
title_sort speckle tracking and transthyretin amyloid cardiomyopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245844/
https://www.ncbi.nlm.nih.gov/pubmed/27992035
http://dx.doi.org/10.5935/abc.20160191
work_keys_str_mv AT rochaalexandremarins speckletrackingandtransthyretinamyloidcardiomyopathy
AT ferreirasuzanegarcia speckletrackingandtransthyretinamyloidcardiomyopathy
AT nacifmarcelosouto speckletrackingandtransthyretinamyloidcardiomyopathy
AT ribeiromarioluiz speckletrackingandtransthyretinamyloidcardiomyopathy
AT defreitasmarcosraimundogomes speckletrackingandtransthyretinamyloidcardiomyopathy
AT mesquitaclaudiotinoco speckletrackingandtransthyretinamyloidcardiomyopathy